Silverfin false false 28/11/2024 29/11/2023 28/11/2024 James Sutherland 29/02/2008 Nicole Sutherland 10/05/2016 01 July 2025 The principal activity of this company during the period was the operation of a nursing home. 06518421 2024-11-28 06518421 bus:Director1 2024-11-28 06518421 bus:Director2 2024-11-28 06518421 2023-11-28 06518421 core:CurrentFinancialInstruments 2024-11-28 06518421 core:CurrentFinancialInstruments 2023-11-28 06518421 core:ShareCapital 2024-11-28 06518421 core:ShareCapital 2023-11-28 06518421 core:RetainedEarningsAccumulatedLosses 2024-11-28 06518421 core:RetainedEarningsAccumulatedLosses 2023-11-28 06518421 core:LandBuildings 2023-11-28 06518421 core:Vehicles 2023-11-28 06518421 core:FurnitureFittings 2023-11-28 06518421 core:LandBuildings 2024-11-28 06518421 core:Vehicles 2024-11-28 06518421 core:FurnitureFittings 2024-11-28 06518421 core:OtherSubsidiariesTotalIndividuallyImmaterialSubsidiaries core:CurrentFinancialInstruments 2024-11-28 06518421 core:OtherSubsidiariesTotalIndividuallyImmaterialSubsidiaries core:CurrentFinancialInstruments 2023-11-28 06518421 core:ImmediateParent core:CurrentFinancialInstruments 2024-11-28 06518421 core:ImmediateParent core:CurrentFinancialInstruments 2023-11-28 06518421 2022-11-28 06518421 bus:OrdinaryShareClass1 2024-11-28 06518421 bus:OrdinaryShareClass2 2024-11-28 06518421 bus:OrdinaryShareClass3 2024-11-28 06518421 bus:OrdinaryShareClass4 2024-11-28 06518421 2023-11-29 2024-11-28 06518421 bus:FilletedAccounts 2023-11-29 2024-11-28 06518421 bus:SmallEntities 2023-11-29 2024-11-28 06518421 bus:AuditExemptWithAccountantsReport 2023-11-29 2024-11-28 06518421 bus:PrivateLimitedCompanyLtd 2023-11-29 2024-11-28 06518421 bus:Director1 2023-11-29 2024-11-28 06518421 bus:Director2 2023-11-29 2024-11-28 06518421 core:LandBuildings core:TopRangeValue 2023-11-29 2024-11-28 06518421 core:Vehicles 2023-11-29 2024-11-28 06518421 core:FurnitureFittings 2023-11-29 2024-11-28 06518421 2022-11-29 2023-11-28 06518421 core:LandBuildings 2023-11-29 2024-11-28 06518421 bus:OrdinaryShareClass1 2023-11-29 2024-11-28 06518421 bus:OrdinaryShareClass1 2022-11-29 2023-11-28 06518421 bus:OrdinaryShareClass2 2023-11-29 2024-11-28 06518421 bus:OrdinaryShareClass2 2022-11-29 2023-11-28 06518421 bus:OrdinaryShareClass3 2023-11-29 2024-11-28 06518421 bus:OrdinaryShareClass3 2022-11-29 2023-11-28 06518421 bus:OrdinaryShareClass4 2023-11-29 2024-11-28 06518421 bus:OrdinaryShareClass4 2022-11-29 2023-11-28 iso4217:GBP xbrli:pure xbrli:shares

Company No: 06518421 (England and Wales)

ST. JAMES'S LODGE HEALTHCARE LTD

Unaudited Financial Statements
For the financial year ended 28 November 2024
Pages for filing with the registrar

ST. JAMES'S LODGE HEALTHCARE LTD

Unaudited Financial Statements

For the financial year ended 28 November 2024

Contents

ST. JAMES'S LODGE HEALTHCARE LTD

STATEMENT OF FINANCIAL POSITION

As at 28 November 2024
ST. JAMES'S LODGE HEALTHCARE LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 28 November 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 1,014,065 1,041,028
1,014,065 1,041,028
Current assets
Debtors 4 87,972 69,050
Cash at bank and in hand 4,223 6,397
92,195 75,447
Creditors: amounts falling due within one year 5 ( 956,624) ( 1,011,325)
Net current liabilities (864,429) (935,878)
Total assets less current liabilities 149,636 105,150
Provision for liabilities 6 ( 38,844) ( 39,892)
Net assets 110,792 65,258
Capital and reserves
Called-up share capital 7 1,030 1,030
Profit and loss account 109,762 64,228
Total shareholder's funds 110,792 65,258

For the financial year ending 28 November 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of St. James's Lodge Healthcare Ltd (registered number: 06518421) were approved and authorised for issue by the Board of Directors on 01 July 2025. They were signed on its behalf by:

James Sutherland
Director
ST. JAMES'S LODGE HEALTHCARE LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 28 November 2024
ST. JAMES'S LODGE HEALTHCARE LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 28 November 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

St. James's Lodge Healthcare Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Bishop Fleming Brook House Manor Drive, Clyst St. Mary, Exeter, EX5 1GD, United Kingdom. The principal place of business is 74 Molesworth Rd, Stoke, Plymouth, PL1 5PF.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Statement of Financial Position.

Finance costs

Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line/reducing balance basis over its expected useful life, as follows:

Land and buildings not depreciated
50 years straight line
Vehicles 25 % reducing balance
Fixtures and fittings 25 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 40 36

3. Tangible assets

Land and buildings Vehicles Fixtures and fittings Total
£ £ £ £
Cost
At 29 November 2023 1,357,362 4,475 193,194 1,555,031
Additions 0 0 5,924 5,924
At 28 November 2024 1,357,362 4,475 199,118 1,560,955
Accumulated depreciation
At 29 November 2023 363,616 4,402 145,985 514,003
Charge for the financial year 20,647 18 12,222 32,887
At 28 November 2024 384,263 4,420 158,207 546,890
Net book value
At 28 November 2024 973,099 55 40,911 1,014,065
At 28 November 2023 993,746 73 47,209 1,041,028

4. Debtors

2024 2023
£ £
Trade debtors 30,356 501
Amounts owed by fellow subsidiaries 57,616 35,236
Prepayments 0 1,600
Corporation tax 0 31,713
87,972 69,050

5. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 46,561 33,581
Amounts owed to Parent undertakings 261,790 260,790
Amounts owed to fellow subsidiaries 27,205 60,321
Amounts owed to directors 533,227 505,282
Accruals 0 3,433
Taxation and social security 21,149 89,068
Other creditors 66,692 58,850
956,624 1,011,325

6. Deferred tax

2024 2023
£ £
At the beginning of financial year ( 39,892) ( 63,084)
Credited to the Statement of Income and Retained Earnings 1,048 23,192
At the end of financial year ( 38,844) ( 39,892)

7. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
1,000 A ordinary shares of £ 1.00 each 1,000 1,000
10 B ordinary shares of £ 1.00 each 10 10
10 C ordinary shares of £ 1.00 each 10 10
10 D ordinary shares of £ 1.00 each 10 10
1,030 1,030

8. Financial commitments

Pensions

The Company operates a defined contribution pension scheme for the directors and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund.

2024 2023
£ £
Unpaid contributions due to the fund (inc. in other creditors) 3,204 2,770

9. Related party transactions

Transactions with owners holding a participating interest in the entity

As the Company is a 100% subsidiary of Mayhaven Healthcare Limited, the company has taken advantage of the exemption contained in s. 1AC.35 of FRS102, and has therefore not disclosed transactions or balances with its parent company.

Transactions with the entity's directors

2024 2023
£ £
Amounts owed to the directors 533,227 505,282

The amounts are repayable on demand and no interest is charged on the balances.